80_FR_46475 80 FR 46326 - Manufacturer of Controlled Substances Registration: National Center for Natural Products Research (NIDA MPROJECT), Inc.

80 FR 46326 - Manufacturer of Controlled Substances Registration: National Center for Natural Products Research (NIDA MPROJECT), Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 149 (August 4, 2015)

Page Range46326-46327
FR Document2015-19172

National Center for Natural Products Research (NIDA MPROJECT), Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants National Center for Natural Products Research (NIDA MPROJECT), Inc. registration as a manufacturer of those controlled substances.

Federal Register, Volume 80 Issue 149 (Tuesday, August 4, 2015) 
[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Pages 46326-46327]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19172]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: National 
Center for Natural Products Research (NIDA MPROJECT), Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: National Center for Natural Products Research (NIDA MPROJECT), 
Inc. applied to be registered as a manufacturer of certain basic 
classes of controlled substances. The Drug Enforcement Administration 
(DEA) grants National Center for Natural Products Research (NIDA 
MPROJECT), Inc. registration as a manufacturer of those controlled 
substances.

SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and 
published in the Federal Register on April 22, 2015, 80 FR 22559, 
National Center for Natural Products Research (NIDA MPROJECT), Inc., 
University of Mississippi, 135 Coy Waller Complex, University, 
Mississippi 38677-1848 applied to be registered as a manufacturer of 
certain basic classes of controlled substances. No comments or 
objections were submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of National Center for Natural 
Products Research (NIDA MPROJECT), Inc. to manufacture the basic 
classes of controlled substances is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. The DEA 
investigated the company's maintenance of effective controls against 
diversion by inspecting and testing the company's physical security 
systems, verifying the company's compliance with state and local laws, 
and reviewing the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances:

[[Page 46327]]



------------------------------------------------------------------------
               Controlled substance                       Schedule
------------------------------------------------------------------------
Marihuana (7360).................................  I
Tetrahydrocannabinols (7370).....................  I
------------------------------------------------------------------------

    The company plans to cultivate marihuana in support of the National 
Institute on Drug Abuse for research approved by the Department of 
Health and Human Services.

    Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19172 Filed 8-3-15; 8:45 am]
BILLING CODE P

46326 Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices with a hearing to challenge the State’s registration. Simply put, there is no DEPARTMENT OF JUSTICE action at which he may ultimately contested factual matter adducible at a prevail.’’ Kamal Tiwari, M.D., 76 FR hearing that would provide DEA with Drug Enforcement Administration 71604, 71606, (2011); see also Bourne the authority to allow the Respondent to Pharmacy, Inc., 72 FR 18273, 18274 continue to hold his COR. [Docket No. DEA–392] (2007); Anne Lazar Thorn, 62 FR 12847 Accordingly, I hereby (1997). Additionally, Agency precedent GRANT the Government’s Motion for Manufacturer of Controlled has established that the existence of Summary Disposition; and further Substances Registration: National other proceedings in which the DENY the Respondent’s Request for Center for Natural Products Research Respondent is involved is not a basis Stay; and further (NIDA MPROJECT), Inc. upon which to justify a stay of DEA RECOMMEND that the Respondent’s administrative enforcement DEA registration be REVOKED forthwith ACTION: Notice of registration. proceedings. Grider Drug #1 & Grider and any pending applications for Drug #2, 77 FR 44069, 44104 n.97 renewal be DENIED. SUMMARY: National Center for Natural (2012). Dated: March 20, 2015. Products Research (NIDA MPROJECT), Congress does not intend for JOHN J. MULROONEY, II, Inc. applied to be registered as a administrative agencies to perform Chief Administrative Law Judge. manufacturer of certain basic classes of meaningless tasks. See Philip E. Kirk, controlled substances. The Drug [FR Doc. 2015–19119 Filed 8–3–15; 8:45 am] M.D., 48 FR 32887 (1983), aff’d sub Enforcement Administration (DEA) BILLING CODE 4410–09–P nom. Kirk v. Mullen, 749 F.2d 297 (6th grants National Center for Natural Cir. 1984); see also Puerto Rico Products Research (NIDA MPROJECT), Aqueduct & Sewer Auth. v. EPA, 35 DEPARTMENT OF JUSTICE Inc. registration as a manufacturer of F.3d 600, 605 (1st Cir. 1994); NLRB v. those controlled substances. Int’l Assoc. of Bridge, Structural & Drug Enforcement Administration SUPPLEMENTARY INFORMATION: By notice Ornamental Ironworkers, AFL–CIO, 549 [Docket No. 12–49] dated April 14, 2015, and published in F.2d 634 (9th Cir. 1977); United States the Federal Register on April 22, 2015, v. Consol. Mines & Smelting Co., 455 AIM Pharmacy & Surgical S. Corp. 80 FR 22559, National Center for F.2d 432, 453 (9th Cir. 1971). Thus, it Order Natural Products Research (NIDA is well-settled that, where no genuine MPROJECT), Inc., University of question of fact is involved, or when the On May 8, 2015, the Administrator of Mississippi, 135 Coy Waller Complex, material facts are agreed upon, a the Drug Enforcement Administration, University, Mississippi 38677–1848 plenary, adversarial administrative noting that the expiration date of applied to be registered as a proceeding is not required. See Jesus R. Respondent’s registration was June 30, manufacturer of certain basic classes of Juarez, M.D., 62 FR 14945 (1997); 2014, ordered the parties to address controlled substances. No comments or Dominick A. Ricci, M.D., 58 FR 51104 whether the case is now moot. The objections were submitted for this (1993). Here, the supplied IDFPR Order Administrator’s Order was served on notice. establishes, and the Respondent does Respondent’s counsel at his address of The DEA has considered the factors in not contest, that the Respondent is record. 21 U.S.C. 823(a) and determined that The Government filed a timely the registration of National Center for currently without authorization to response and served a copy of its Natural Products Research (NIDA handle controlled substances in Illinois, response on Respondent’s counsel at his MPROJECT), Inc. to manufacture the the jurisdiction where the Respondent address of record. Govt. Response to basic classes of controlled substances is holds the DEA COR that is the subject Administrator’s May 8, 2015 Order, at 1. consistent with the public interest and of this litigation. Respondent has not filed a response.1 with United States obligations under Summary disposition of an In its Response, the Government administrative case is warranted where, international treaties, conventions, or advises that Respondent neither as here, ‘‘there is no factual dispute of protocols in effect on May 1, 1971. The submitted a renewal application prior to substance.’’ See Veg-Mix, Inc., 832 F.2d DEA investigated the company’s the expiration of its registration nor an 601, 607 (D.C. Cir. 1987) (‘‘an agency maintenance of effective controls application for a new registration. Id. may ordinarily dispense with a hearing against diversion by inspecting and The Government therefore when no genuine dispute exists’’).4 At testing the company’s physical security acknowledges that this case is now this juncture, no genuine dispute exists systems, verifying the company’s moot. Id.; see Ronald J. Riegel, 63 FR over the fact that the Respondent lacks compliance with state and local laws, 67132, 67133 (1998). Accordingly, I state authority to handle controlled and reviewing the company’s dismiss the Order to Show Cause. substances in the state of Illinois. It is so ordered. background and history. Because the Respondent lacks such state Therefore, pursuant to 21 U.S.C. authority, both the plain language of Date: July 27, 2015. 823(a), and in accordance with 21 CFR applicable federal statutory provisions Chuck Rosenberg, 1301.33, the above-named company is and Agency interpretive precedent Acting Administrator. granted registration as a bulk dictate that the Respondent is not [FR Doc. 2015–19116 Filed 8–3–15; 8:45 am] manufacturer of the basic classes of entitled to maintain his DEA BILLING CODE 4410–09–P controlled substances: tkelley on DSK3SPTVN1PROD with NOTICES 4 Even assuming, arguendo, the possibility that pending in the state courts. Michael G. Dolin, M.D., different address than that listed in the record. the Respondent’s state controlled substances 65 FR 5661, 5662 (2000). Notice of Recent Order and Government’s Response privileges could be reinstated, summary disposition 1 After both the Administrator’s Order and the II, at 1–2. The Government represents that on June would still be warranted because ‘‘revocation is also 30, 2015, it served both the Administrator’s Order Government’s Response were returned to the appropriate when a state license has been Agency as undelivered following efforts to serve and its Response on each of Respondent’s attorneys suspended, but with the possibility of future reinstatement,’’ Rodriguez, 70 FR at 33207 (citations both of Respondent’s counsels, the Government by mailing them to the addresses of Respondent’s omitted), and even where there is a judicial determined through the New York State Unified attorneys as listed in the New York Unified Court challenge to the state medical board action actively Court System’s database that each attorney had a System’s database. Id. at 2. VerDate Sep<11>2014 18:45 Aug 03, 2015 Jkt 235001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\04AUN1.SGM 04AUN1

Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices 46327 Controlled substance Schedule Marihuana (7360) ........................................................................................................................................................................................ I Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I The company plans to cultivate SUMMARY: Sigma-Aldrich International The DEA has considered the factors in marihuana in support of the National GMBH, Sigma Aldrich Co., LLC applied 21 U.S.C. 823, 952(a) and 958(a) and Institute on Drug Abuse for research to be registered as an importer of certain determined that the registration of approved by the Department of Health basic classes of controlled substances. Sigma-Aldrich International GMBH, and Human Services. The Drug Enforcement Administration Sigma Aldrich Co., LLC to import the Dated: July 29, 2015. (DEA) grants Sigma-Aldrich basic classes of controlled substances is Joseph T. Rannazzisi, International GMBH, Sigma Aldrich Co., consistent with the public interest and LLC registration as an importer of those with United States obligations under Deputy Assistant Administrator. controlled substances. international treaties, conventions, or [FR Doc. 2015–19172 Filed 8–3–15; 8:45 am] SUPPLEMENTARY INFORMATION: By notice protocols in effect on May 1, 1971. The BILLING CODE P DEA investigated the company’s dated April 14, 2015, and published in the Federal Register on April 22, 2015, maintenance of effective controls 80 FR 22552, Sigma-Aldrich against diversion by inspecting and DEPARTMENT OF JUSTICE International GMBH, Sigma Aldrich Co., testing the company’s physical security Drug Enforcement Administration LLC, 3500 Dekalb Street, St. Louis, systems, verifying the company’s Missouri 63118 applied to be registered compliance with state and local laws, [Docket No. DEA–392] as an importer of certain basic classes of and reviewing the company’s controlled substances. No comments or background and history. Importer of Controlled Substances objections were submitted for this Therefore, pursuant to 21 U.S.C. Registration: Sigma-Aldrich notice. Comments and requests for 952(a) and 958(a), and in accordance International GMBH, Sigma Aldrich hearings on applications to import with 21 CFR 1301.34, the above-named Co., LLC narcotic raw material are not company is granted registration as an appropriate. 72 FR 3417, (January 25, importer of the basic classes controlled ACTION: Notice of registration. 2007). substances: Controlled substance Schedule Cathinone (1235) ......................................................................................................................................................................................... I Methcathinone (1237) .................................................................................................................................................................................. I Mephedrone (4-Methyl-N-methylcathinone (1248) ...................................................................................................................................... I N-Ethylamphetamine (1475) ........................................................................................................................................................................ I Aminorex (1585) .......................................................................................................................................................................................... I Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... I Methaqualone (2565) .................................................................................................................................................................................. I Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I Ibogaine (7260) ........................................................................................................................................................................................... I Lysergic acid diethylamide (7315) ............................................................................................................................................................... I Marihuana (7360) ........................................................................................................................................................................................ I Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I Mescaline (7381) ......................................................................................................................................................................................... I 4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. I 3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 4-Methoxyamphetamine (7411) ................................................................................................................................................................... I Bufotenine (7433) ........................................................................................................................................................................................ I Diethyltryptamine (7434) ............................................................................................................................................................................. I Dimethyltryptamine (7435) .......................................................................................................................................................................... I Psilocybin (7437) ......................................................................................................................................................................................... I Psilocyn (7438) ............................................................................................................................................................................................ I 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... I N-Benzylpiperazine (7493) .......................................................................................................................................................................... I MDPV (3,4-Methylenedioxypyrovalerone) (7535) ....................................................................................................................................... I Heroin (9200) ............................................................................................................................................................................................... I Normorphine (9313) .................................................................................................................................................................................... I tkelley on DSK3SPTVN1PROD with NOTICES Etonitazene (9624) ...................................................................................................................................................................................... I Amphetamine (1100) ................................................................................................................................................................................... II Methamphetamine (1105) ........................................................................................................................................................................... II Methylphenidate (1724) ............................................................................................................................................................................... II Amobarbital (2125) ...................................................................................................................................................................................... II Pentobarbital (2270) .................................................................................................................................................................................... II Secobarbital (2315) ..................................................................................................................................................................................... II VerDate Sep<11>2014 18:45 Aug 03, 2015 Jkt 235001 PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\04AUN1.SGM 04AUN1


Document Created: 2015-12-18 14:51:55
Document Modified: 2015-12-18 14:51:55
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of registration.
FR Citation80 FR 46326 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR